– Company Presents Poster on Overall Survival and Long-Term Safety Results from INTRIGUE Study; Second Poster Presents Analysis from INTRIGUE Patients without Detectable ctDNA at Baseline. | May 25, 2023
Deciphera Pharmaceuticals (DCPH) Presents Results from ctDNA Analysis of INTRIGUE Phase 3 Clinical Study streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
New versatile instrument for magnetism research at ID12 esrf.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from esrf.fr Daily Mail and Mail on Sunday newspapers.